Stoke Therapeutics | Company Profile - Revenue, Headcount, Tech Stack, Contacts
Industry & Market
No industry information available
Funding Information
No funding information available
Headcount Distribution
No headcount data available
Department Breakdown
No department data available
Keywords & Focus Areas
No keywords available
Overview
Stoke Therapeutics is a biotechnology company dedicated to developing RNA-based precision medicines aimed at treating severe genetic diseases. Founded in 2014 by Professor Adrian Krainer, Ph.D., Isabel Aznarez, Ph.D., and Huw Nash, Ph.D., the company utilizes proprietary insights into RNA splicing and metabolism pathways to create therapies that address the underlying causes of diseases related to haploinsufficiency.
The company’s TANGO technology platform enables the development of medicines that enhance protein production by modulating RNA splicing. Its lead product candidate, zorevunersen (STK-001), is advancing through clinical trials for Dravet syndrome, a serious genetic epilepsy, while programs for other haploinsufficient diseases such as autosomal dominant optic atrophy (ADOA) are also in development. Stoke Therapeutics remains committed to a patient-centered mission, scientific rigor, and a collaborative workplace culture.
Key Metrics
Get Complete Company Metrics
Dive deeper into employee structure, funding, revenue, and key performance indicators all in one place.
Contact
Technology Stack
Analytics & Tracking
Social & Marketing
Database & Backend
Cloud & Infrastructure
Productivity
Compare similar companies to
Compare insights from companies similar to , focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
| Company Name | Revenue | No. of Employees | Type | Funding | Founded In | Top Executive |
|---|---|---|---|---|---|---|
| xxxxxxx | $17490 | 104 | Private | - | 3034 | xxxxxx |
| xxxxxxxx | $85358 | 39 | Private | - | 3342 | xxxxxxxxxx |
| xxxx | $18854 | 64 | Private | - | 1370 | xxxxxxxxx |
| xxxxxxxxxx | $18351 | 96 | Private | - | 3866 | xxxxxxx |
| xxxxx | $35041 | 5 | Private | - | 3953 | xxxxxxxxx |
Discover Similar Companies Instantly
Explore detailed insights and analysis on companies related to your search.